<div id="readability-page-1"><p>Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.08), Zacks reports. Bioceres Crop Solutions had a negative return on equity of 14.72% and a negative net margin of 15.27%.</p><h2>Bioceres Crop Solutions Price Performance</h2><ul><li>3 Bargain Stocks Under $20 With Major Growth Potential</li></ul><p>BIOX traded down $0.06 during midday trading on Wednesday, reaching $1.87. 1,185,196 shares of the company's stock were exchanged, compared to its average volume of 1,248,524. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. Bioceres Crop Solutions has a 1-year low of $1.20 and a 1-year high of $7.44. The stock has a market capitalization of $118.24 million, a PE ratio of -2.31 and a beta of 0.42. The business's 50-day moving average price is $1.79 and its 200 day moving average price is $3.27. </p><h2>Institutional Investors Weigh In On Bioceres Crop Solutions</h2><p>Several hedge funds have recently modified their holdings of the company. Bank of America Corp DE lifted its stake in shares of  Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares during the period.  Jones Financial Companies Lllp raised its holdings in  Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after acquiring an additional 5,339 shares during the last quarter.  Jane Street Group LLC purchased a new position in shares of  Bioceres Crop Solutions during the 2nd quarter worth $202,000.  Finally, PDT Partners LLC boosted its holdings in shares of  Bioceres Crop Solutions by 58.9% during the second quarter. PDT Partners LLC now owns 28,180 shares of the company's stock worth $126,000 after purchasing an additional 10,449 shares during the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds. </p><h2>Analysts Set New Price Targets</h2><p>A number of equities research analysts have issued reports on the stock. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, September 10th. Oppenheimer downgraded Bioceres Crop Solutions from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a research note on Wednesday, October 22nd. Canaccord Genuity Group  reaffirmed a &#34;hold&#34; rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday, September 10th. Brookline Capital Management downgraded Bioceres Crop Solutions from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, August 21st. Finally, Wall Street Zen downgraded Bioceres Crop Solutions from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, September 13th. One analyst  has rated the stock with a Buy rating, three have issued  a Hold rating and one  has issued  a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average target price of $4.17.</p><p><b>View Our Latest Analysis on Bioceres Crop Solutions</b></p><h2>Bioceres Crop Solutions Company Profile</h2> (Get Free Report)<p>Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.</p><h2>See Also</h2><ul><li>Five stocks we like better than Bioceres Crop Solutions</li><li>Dividend Capture Strategy: What You Need to Know</li><li>Rare Earth Stocks: The Truce That Isn't a Truce</li><li>Short Selling - The Pros and Cons </li><li>Carving Up Profits: 3 Food Stocks on the Thanksgiving Table</li><li>What is Insider Trading? What You Can Learn from Insider Trading</li><li>C3.ai's Reset: Why New Leadership Could Spark a Turnaround</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Bioceres Crop Solutions Right Now?</h2><p>Before you consider Bioceres Crop Solutions, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.</p><p>While Bioceres Crop Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BIOX

<p>Bioceres Crop Solutions (NASDAQ:BIOX) reported a quarterly EPS of ($0.12), missing the consensus estimate of ($0.04) by $0.08. The company had a negative net margin of 15.27% and a negative return on equity of 14.72%. The stock traded down $0.06 to $1.87. Analysts have adjusted their ratings and price targets, with some downgrading the stock. Institutional investors have modified their holdings, with 17.68% of the stock owned by them.</p>

Bioceres Crop Solutions (NASDAQ:BIOX) Posts Earnings Results, Misses Expectations By $0.08 EPS